Overview: Melphalan 50 mg Injection contains Melphalan (50 mg) as a lyophilized powder and is a prescription antineoplastic alkylating chemotherapy medicine used in the treatment of multiple myeloma, advanced ovarian cancer and select solid tumours by interfering with DNA replication in cancer cells. Key Benefits: – Effective in the treatment of multiple myeloma and ovarian cancer – Interferes with DNA synthesis in malignant cells to slow tumour progression – Administered under clinical supervision Composition: Melphalan (50 mg) How It Works: Melphalan is an alkylating agent that forms cross-links in DNA, preventing cancer cell division and leading to cell death, particularly in rapidly dividing tumour cells. Usage Instructions: – Administer only by qualified healthcare professionals – Reconstitute the lyophilized powder with diluent as directed prior to use – Not for self-administration Side Effects: – Nausea, vomiting, low blood cell counts – Hair loss, fatigue, mouth sores – Increased infection and bleeding risk due to bone marrow suppression Precautions: – Regular monitoring of blood counts and organ function is essential – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Celon Labs Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.